Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.

At Shire, we enable people with life altering conditions to lead better lives. We focus on developing and delivering innovative treatments for patients with rare diseases and other specialty conditions. 

To realize our aspiration to become a leading global biotech, our efforts are concentrated on four key strategic drivers: growth, innovation, efficiency, and people. Our priorities are to drive optimal performance of our existing products, increase patient access to these medicines, and to build our pipeline through research and development and partnerships in order to deliver new medicines to patients.
Jersey, GB
5,548 (est)+11%

Key People at Shire

Graham Hetherington

Graham Hetherington

Chief Financial Officer
William Burns

William Burns

Non-Executive Director
Susan Kilsby

Susan Kilsby

Non-Executive Director
David Kappler

David Kappler

Deputy Chairman
Steven Gillis

Steven Gillis

Non-Executive Director

Shire Locations

Jersey, GB
Saint-Laurent, CA
Berlin, DE
Zug, CH
São Paulo, BR
Boulogne Billancourt, FR
Lexington, US
Tokyo, JP
Singapore, SG
Madrid, ES
Dublin, IE
Mexico City, MX
Vienna, AT
Zürich, CH
Beijing, CN
Shanghai, CN
Washington, US
Sofia, BG
Ontario, US
Reading, US

Shire Metrics

Shire Summary

Founding Date


Market capitalization

$54.9 B

Closing share price


Shire Market Value History

Shire News

Shire Company Life